Butantan Foundation

The Butantan Foundation is a private-law, non-profit civil entity established to support Instituto Butantan, an agency affiliated with the São Paulo State Secretariat of Health. The Foundation is responsible for developing scientific, technological, cultural, and educational activities, as well as the production of immunobiologicals.


University of São Paulo Medical School (FMUSP)

Founded in 1912, the University of São Paulo Medical School (FMUSP) is renowned for its pioneering spirit and excellence in education and research. It offers five undergraduate programs (Medicine, Physical Therapy, Speech-Language Pathology and Audiology, Occupational Therapy, and Medical Physics) and houses 66 medical research laboratories, with an average of 2,500 scientific articles published annually.


Municipal University of São Caetano do Sul (USCS)

The Municipal University of São Caetano do Sul (USCS) offers more than 40 undergraduate programs, along with various specializations, distributed across five campuses. In its 50-year history, the institution has graduated more than 30,000 alumni. Established in 2014, the USCS Medical School operates within hospital complexes in both São Caetano do Sul and the city of São Paulo.


University of Oxford

Established in 1090 in England, the University of Oxford is one of the oldest higher education and research institutions in the world. It comprises 38 colleges and approximately 250 undergraduate programs. Oxford is one of Europe's leading innovation hubs, with particular strength in the biosciences and emerging technologies.


Blue Water Vaccines Inc.

The North American biotechnology company is developing a single-dose universal flu vaccine, utilizing technology developed by scientists at the University of Oxford.


Mabloc LLC

An independent laboratory dedicated to the development of monoclonal antibodies for the treatment of infectious diseases, including yellow fever, Zika, and COVID-19, as well as viruses within the betacoronavirus genus.


Bionovis SA

Bionovis is a pharmaceutical biotechnology joint venture formed by four leaders in the Brazilian pharmaceutical market (Aché, EMS, Hypera Pharma, and União Química), with the goal of promoting the research, development, production, and commercialization of biopharmaceuticals in Brazil.